Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT06916728
Enrolling by invitation Observational

A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Care (SSOC) Used for the Treatment of Joint Surface Lesions of the Knee

NCT06916728 · tracked via the Priya Life Science Italy tracker
Sponsor
Smith & Nephew, Inc
Phase
Observational
Started
2025-05-05
Last updated
2026-07-16

Condition(s) studied

Knee InjuriesJoint Surface Knee Lesions

Investigational drug(s) / intervention(s)

Marketed Product - MP01Surgical Standard of Care

Marketed Product - MP01: Marketed Product - MP01 was implanted via a mini-arthrotomy or arthrotomy approach, using the designated surgical tools and surgical technique.

Surgical Standard of Care: As no single, current therapy could be used as a single comparator for the treatment of the knee lesions treated in the pivotal study which included focal cartilage lesions on the one hand and moderate knee osteoarthritis on the other, current general practice (e.g., SSOC: Deb and MFx) was used. Deb (SSOC) is a common orthopedic surgical procedure that removes damaged cartilage and tissue from the knee. MFx (SSOC) is another common orthopedic surgical procedure that treats knee cartilage defects by creating small holes in the bone beneath the damaged cartilage.

Study summary

The purpose of the study is to support market adoption and global market access via collection of long-term effectiveness, safety, and radiographic data. The primary hypothesis is that Marketed Product (MP01) retains its superiority over Surgical Standard of Care (SSOC) at 7 years in term of mean improvement in the overall Knee Injury and Osteoarthritis Outcome Score (KOOS).

Eligibility

Sex
ALL
Min age
21 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Participated in the pivotal study. 2. Must be physically and mentally willing and able to comply with the follow-up schedule. 3. Signed and dated the IEC/IRB approved Informed Consent Form and HIPPA (if applicable). Exclusion Criteria: 1. Withdrawn from the pivotal study due to index knee requiring a unicompartmental or total knee arthroplasty. 2. Chemotherapy in the past 12 months. 3. Participation in other clinical trials involving knee procedures. 4. Vulnerable individual including prisoners (i.e., unable to fully understand all aspects of the study that are relevant to the decision to participate or could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response).

Primary outcome measure(s)

  • Change from Baseline in Overall Knee Injury and Osteoarthritis Outcome Score (KOOS) at 7 Years — Baseline and 7 years
    Long-term effectiveness of Marketed Product - MP01 compared to SSOC measured by change in baseline to year 7 in overall KOOS (mean of Pain, Symptoms, Quality of Life (QOL), Function in Daily Living (ADL) and Sports subscales) in subjects treated with Marketed Product - MP01 vs SSOC. Baseline is defined as the pivotal study screening visit. Overall scores are converted to a 0-100 scale, with 0 representing extreme knee problems and 100 representing no knee problems (i.e., a lower score is a worse outcome, and high score is a better outcome).

Trial sites (8)

FacilityCityRegionStatus
Horizon Clinical Research La Mesa California
AZ Monica Antwerp Belgium
Hadassah Medical Center Jerusalem Israel
Humanitas Gavazzeni Bergamo Italy
Istituto Clinico Humanitas Milan Italy
County Hospital Timis Othopedy and Trauma Clinic II Timișoara Romania
Institut za Ortopedsko hiruske Bolesti "Banjica" Belgrade Serbia
Klinika Orto MD Novi Sad Serbia

More Smith & Nephew, Inc. trials in Italy

Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee System Active, not recruiting
Evaluation Of Outcomes Following Rotator Cuff Repair Using the REGENETEN Bioinductive Implant Recruiting
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears Recruiting

Other trials for the same condition

Clinical-instrumental Evaluation and Assessment of Return to Sports Activity in Patients Surgically Treated for Isolated "Stener-like" Lesions of the Medial Collateral Ligament (MCL) or in the Context of Multiligament Injuries and Articular Fractures Recruiting
Comparison Between the Use of the Tensioner and Standard Surgical Technique for Ligament Balancing of Total Knee Prostheses Recruiting
Clinical and Instrumental Assessment of Meniscal ROOT Tears Treated Through Suture to the Posterior Cruciate Ligament Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06916728 on ClinicalTrials.gov ↗ ← All trials in Italy